Cite
HARVARD Citation
Pierre, N. et al. (2021). Discovery of biomarker candidates associated with the risk of short-term and mid/long-term relapse after infliximab withdrawal in Crohn's patients: a proteomics-based study. Gut. 70 (8), pp. 1450-1457. [Online].